Urocortin Is a Novel Regulator of Osteoclast Differentiation and Function Through Inhibition of a Canonical Transient Receptor Potential 1-Like Cation Channel

Total Page:16

File Type:pdf, Size:1020Kb

Urocortin Is a Novel Regulator of Osteoclast Differentiation and Function Through Inhibition of a Canonical Transient Receptor Potential 1-Like Cation Channel 187 Urocortin is a novel regulator of osteoclast differentiation and function through inhibition of a canonical transient receptor potential 1-like cation channel Charlotte E Combs, Karen Fuller, Hashethra Kumar, Anthony P Albert, Grisha Pirianov, James McCormick1, Ian C Locke2, Timothy J Chambers and Kevin M Lawrence Department of Cellular Pathology, St George’s, University of London, Cranmer Terrace, London SW17 ORE, UK 1Medical Molecular Biology Unit, Institute of Child Health, University College London, London WC1N 1EH, UK 2Department of Biomedical Sciences, University of Westminster, 115 New Cavendish Street, London W1W 6UW, UK (Correspondence should be addressed to K M Lawrence; Email: [email protected]) Abstract This study investigated the role of urocortin (UCN), a expressed CRF receptor 2b alone. Unstimulated osteoclasts member of the corticotrophin-releasing factor (CRF) family contained constitutively active cation channel currents with of peptides, in osteoclast maturation and function. We found a unitary conductance of 3–4 pS, which were inhibited by K K that 10 7 M UCN significantly (P!0.05) suppressed over 70% with UCN (10 7 M). Compounds that regulate osteoclast differentiation from bone marrow precursor cells calcium signalling and energy status of the cell, both crucial in culture and reduced the expression of several osteoclastic for osteoclast activity were investigated. The non-selective C markers. Furthermore, UCN potently suppressed osteoclast cation channel blockers, lanthanum (La3 ) and gadolinium C bone resorption, by significantly inhibiting both the plan (Gd3 ), inhibited actin ring formation in osteoclasts, C area of bone resorbed by osteoclasts and actin ring formation whereas modulators of voltage-dependent Ca2 channels K9 within osteoclasts at 10 M(P!0.05), with complete and KATP channels had no effect. These findings show for K inhibition at 10 7 M(P!0.001). UCN also inhibited the first time that UCN is a novel anti-resorptive molecule K osteoclast motility (10 7 M) but had no effect on osteoclast that acts through a direct effect on osteoclasts and their survival. Osteoclasts expressed mRNA encoding both UCN precursor cells. and the CRF receptor 2b subtype. Pre-osteoclasts however, Journal of Endocrinology (2012) 212, 187–197 Introduction receptor diversity produced by alternative RNA splicing (Chen et al. 1993, Lovenberg et al. 1995, Perrin & Vale 1999, Urocortin (UCN) is a member of the corticotrophin- Hauger et al. 2003, Fekete & Zorrilla 2007). Radioligand releasing factor (CRF) family of peptides. It was originally binding studies have demonstrated that CRF and UCN cloned from a rat brain cDNA library, using a probe can bind to both CRFR1 and CRFR2, whereas UCN 2 and 3 homologous to CRF (Vaughan et al. 1995). Since then, two bind exclusively to CRFR2. UCN has been shown to act new members have been isolated, UCN 2 and 3, which are predominantly through both Gas and Gaq G-protein subunits equivalent to human stresscopin-related peptide and stressco- to stimulate diverse signalling cascades, through respectively, pin respectively (Hsu & Hsueh 2001, Lewis et al. 2001, Reyes adenylate cyclase (AC) and phospholipase C (PLC) pathways, et al. 2001, Fekete & Zorrilla 2007). All three UCNs are depending on the tissue type (Grammatopoulos et al. synthesised as precursors of w200 amino acids, which are 2000, Cantarella et al. 2001, Graziani et al. 2002, McEvoy then subsequently cleaved to yield the active peptides, which et al.2002, Bayatti et al.2003, Karteris et al.2005). in the case of UCN is 40 amino acids (Fekete & Zorrilla UCN-mediated activation of these signal transduction 2007). The level of functional availability of UCN is closely pathways modulates a variety of end effectors including ion regulated by a high affinity CRF-binding protein (CRF-BP), channels involved in calcium signalling and energy expressed at both release and activation sites of UCN, which metabolism, such as L-type voltage-gated calcium channels, acts as a decoy receptor to terminate the ligand signal (Behan store-operated channels and KATP channels (Lawrence et al. et al. 1995, Seasholtz et al. 2002). 2002, Tao et al. 2004, 2006, Smani et al. 2007). UCN binds to two G-protein-coupled receptor sub- The CRF family members have been linked to a number of types, CRF receptor 1 (CRFR1) and CRFR2, with further physiological and pathological conditions. CRF is the classic Journal of Endocrinology (2012) 212, 187–197 DOI: 10.1530/JOE-11-0254 0022–0795/12/0212–187 q 2012 Society for Endocrinology Printed in Great Britain Online version via http://www.endocrinology-journals.org Downloaded from Bioscientifica.com at 10/01/2021 09:58:39PM via free access 188 C E COMBS and others . Effect of urocortin on osteoclasts mediator of the hypothalamic stress response, initiating an performed at 37 8Cin5%CO2 in humidified air, unless stated anxiogenic, neuroendocrine and behavioural stress pheno- otherwise. Slices of bovine cortical bone were prepared as type. In contrast, UCN plays a more anxiolytic role in this previously described (Fuller et al. 2006). response and is also involved in appetite suppression and energy metabolism (Spina et al. 1996, Smagin et al. 1998, Tanaka et al. 2009). The peptides are also expressed in Generation of osteoclasts peripheral tissue, where they appear to be cytoprotective Osteoclast suspensions were prepared from murine bone through CRFR2, in models of cellular stress (Brar et al. 2002, marrow cells as previously described (Fuller et al. 2006). Lawrence & Latchman 2006). Recently, UCN has been Briefly, MF1 mice (4–8 weeks old) were killed by cervical found to be elevated in the synovial fluid of patients with dislocation in accord with Home Office Ethical Guidelines. rheumatoid arthritis (Kohno et al. 2001, Uzuki et al. 2001) Femora and tibiae were aseptically removed and dissected free and has also been linked to a reduction in inflammation and of adherent soft tissue. The bone ends were removed and the bone erosion in a mouse model of this disease (Gonzalez-Rey marrow cavity was flushed out into a Petri dish by slowly et al. 2007). However, there is little information on the role of injecting PBS at one end of the bone using a sterile 25-gauge UCN in the physiology or pathology of bone. Because UCN needle. The bone marrow suspension was passed repeatedly is the only member of this family capable of binding to both through a 21-gauge needle to obtain a single cell suspension. CRFR1 and 2, its use would give the best chance of detecting Bone marrow cells were then washed, re-suspended in an effect on osteoclasts. MEM/FCS, and incubated at a density of 3!105 cells/ml Osteoclasts are derived from the monocyte macrophage for 24 h in a 75 cm2 flask (Greiner Bio-One, Stonehouse, lineage; they are large multinucleated cells and are the only Gloucestershire, UK) containing M-CSF (50 ng/ml), to cells of the body capable of resorbing bone. They mature to deplete the cell preparations of stromal cells. Non-adherent form large tartrate-resistant acid phosphatase (TRAP) cells were collected by centrifugation and used immediately positive, multinucleated cells in the presence of receptor (pre-osteoclasts) or added to 90 mm diameter cell culture k activator of NF B ligand (RANKL) and macrophage colony dishes (Greiner) in MEM/FCS, containing M-CSF (50 ng/ml), stimulating factor (M-CSF). Upon activation, osteoclasts 6 RANKL (30 ng/ml) and TGF-b1(0.1 ng/ml) (7.2!10 locate to the bone surface and initiate resorption by creating cells in 25 ml for each dish). Cultures were incubated for a sealing zone, which is accompanied by a ruffled border 5 days, when osteoclast numbers are maximal. Cells were fed and actin reorganisation (Va¨a¨na¨nen et al. 2000). Excessive every 2–3 days by replacing 15 ml of culture medium with resorption by these cells is the cause of several common an equal volume of fresh medium and cytokines. When diseases of bone, including osteoporosis. multinuclear cells had formed, the medium was removed and In this study we investigated the effects of UCN on the the cell layer washed three times with PBS without calcium formation and function of osteoclasts. Our results clearly . demonstrate that UCN is a regulator of osteoclast resorption, and magnesium. Six millilitres of 0 02% EDTA were added to by suppressing osteoclast maturation and potently inhibiting the dish and cells incubated for 20 min at room temperature. osteoclastic function. Furthermore, we provide evidence that The EDTA was then removed from the dish and replaced the inhibitory action of UCN on osteoclasts is mediated by with 4 ml calcium/magnesium-free PBS. A cell scraper suppression of constitutively active cation channels that have (Greiner) was used to scrape the cells into the PBS, and the properties characteristic of a canonical transient receptor resulting cell suspension was agitated using a pipette to ensure potential 1 (TRPC1) channel. uniform cell dispersal for further use as described below. Assessment of bone resorption and actin ring formation Materials and Methods Seventy-five microlitres of osteoclast-containing cell suspension were added to wells of a 96-well plate (Greiner), Culture media and reagents each of which contained a bone slice in 75 ml MEM/FCS. Cells were incubated in minimum essential medium (MEM) Cells were allowed to sediment for 20 min at 37 8C with Earle’s salts, supplemented with 10% FCS, 2 mM before the bone slices were washed in PBS and transferred glutamine, 100 IU/ml benzylpenicillin and 100 mg/ml to fresh wells. Cells for assessment of resorption were streptomycin, UCN (all from Sigma), unless stated otherwise. incubated for 4 h in 200 ml MEM/FCS in the presence of Recombinant human M-CSF and soluble recombinant M-CSF (50 ng/ml), RANKL (30 ng/ml), IL1a (10 ng/ml) K K murine RANKL were purchased from PeproTech EC with UCN (10 7–10 10 M) or vehicle.
Recommended publications
  • Corticotropin-Releasing Hormone Physiology
    European Journal of Endocrinology (2006) 155 S71–S76 ISSN 0804-4643 Corticotropin-releasing hormone physiology Joseph A Majzoub Division of Endocrinology, Children’s Hospital Boston, Thomas Morgan Rotch Professor of Pediatrics, Harvard Medical School, 300 Longwood Avenue, Boston, Massachusetts 02115, USA (Correspondence should be addressed to J A Majzoub; Email: [email protected]) Abstract Corticotropin-releasing hormone (CRH), also known as corticotropin-releasing factor, is a highly conserved peptide hormone comprising 41 amino acid residues. Its name derives from its role in the anterior pituitary, where it mediates the release of corticotropin (ACTH) leading to the release of adrenocortical steroids. CRH is the major hypothalamic activator of the hypothalamic–pituitary– adrenal (HPA)axis. Major functions of the HPAinclude: (i) influencing fetal development of major organ systems including lung, liver, and gut, (ii) metabolic functions, including the maintenance of normal blood glucose levels during the fasting state via glycogenolysis and gluconeogenesis, (iii) modulation of immune function, and (iv) maintenance of cardiovascular tone. In addition, CRH, acting both directly and via the HPA, has a role in regulating several neuroendocrine functions including behavior, food intake, reproduction, growth, immune function, and autonomic function. CRH has been localized to the paraventricular nucleus (PVN) of the hypothalamus, which projects to the median eminence and other hypothalamic and midbrain targets. The CRH gene is composed of two exons. The CRH promoter contains a cAMP-response element, and the intron contains a restrictive element-1/neuron restrictive silencing element (RE-1/NRSE) sequence. Recently, a family of CRH-related peptides, termed the urocortins, has been identified.
    [Show full text]
  • Expression of Urocortin and Corticotropin-Releasing Hormone Receptors in the Horse Thyroid Gland
    Cell Tissue Res DOI 10.1007/s00441-012-1450-4 REGULAR ARTICLE Expression of urocortin and corticotropin-releasing hormone receptors in the horse thyroid gland Caterina Squillacioti & Adriana De Luca & Sabrina Alì & Salvatore Paino & Giovanna Liguori & Nicola Mirabella Received: 11 January 2012 /Accepted: 3 May 2012 # Springer-Verlag 2012 Abstract Urocortin (UCN) is a 40-amino-acid peptide and UCN, CRHR1 and CRHR2 and that UCN plays a role in a member of the corticotropin-releasing hormone (CRH) the regulation of thyroid physiological functions through a family, which includes CRH, urotensin I, sauvagine, paracrine mechanism. UCN2 and UCN3. The biological actions of CRH family peptides are mediated via two types of G-protein-coupled Keywords Follicular cells . C-cells . RT-PCR . receptors, namely CRH type 1 receptor (CRHR1) and CRH Immunohistochemistry . Horse type 2 receptor (CRHR2). The biological effects of these peptides are mediated and modulated not only by CRH receptors but also via a highly conserved CRH-binding Introduction protein (CRHBP). Our aim was to investigate the expression of UCN, CRHR1, CRHR2 and CRHBP by immunohisto- Urocortin (UCN) is a peptide of 40 amino acids and is a chemistry, Western blot and reverse transcription with the member of the corticotropin-releasing hormone (CRH) fam- polymerase chain reaction (RT-PCR) in the horse thyroid ily, which includes CRH, urotensin I, sauvagine, UCN2 and gland. The results showed that UCN, CRHR1 and CRHR2 UCN3. Vaughan et al. (1995) were the first to identify UCN, were expressed in the thyroid gland, whereas CRHBP was which exhibits 45% homology to CRH (Latchman 2002; not expressed.
    [Show full text]
  • Searching for Novel Peptide Hormones in the Human Genome Olivier Mirabeau
    Searching for novel peptide hormones in the human genome Olivier Mirabeau To cite this version: Olivier Mirabeau. Searching for novel peptide hormones in the human genome. Life Sciences [q-bio]. Université Montpellier II - Sciences et Techniques du Languedoc, 2008. English. tel-00340710 HAL Id: tel-00340710 https://tel.archives-ouvertes.fr/tel-00340710 Submitted on 21 Nov 2008 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. UNIVERSITE MONTPELLIER II SCIENCES ET TECHNIQUES DU LANGUEDOC THESE pour obtenir le grade de DOCTEUR DE L'UNIVERSITE MONTPELLIER II Discipline : Biologie Informatique Ecole Doctorale : Sciences chimiques et biologiques pour la santé Formation doctorale : Biologie-Santé Recherche de nouvelles hormones peptidiques codées par le génome humain par Olivier Mirabeau présentée et soutenue publiquement le 30 janvier 2008 JURY M. Hubert Vaudry Rapporteur M. Jean-Philippe Vert Rapporteur Mme Nadia Rosenthal Examinatrice M. Jean Martinez Président M. Olivier Gascuel Directeur M. Cornelius Gross Examinateur Résumé Résumé Cette thèse porte sur la découverte de gènes humains non caractérisés codant pour des précurseurs à hormones peptidiques. Les hormones peptidiques (PH) ont un rôle important dans la plupart des processus physiologiques du corps humain.
    [Show full text]
  • Corticotropin-Releasing Factor, Neuroplasticity (Sensitization), and Alcoholism
    COMMENTARY Corticotropin-releasing factor, neuroplasticity (sensitization), and alcoholism George F. Koob* Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA 92037 ensitization is a ubiquitous bio- logical phenomenon that has a role in the neuroadaptation of many different functions, from Slearning and memory to stress respon- sivity. Historically, a specific form of sensitization termed psychomotor sensi- tization (mistermed in my view as ‘‘be- havioral sensitization’’) is induced by repeated administration of drugs of abuse and has been linked to the neuro- adaptive changes associated with increased drug-seeking behavior associ- Fig. 1. CNS actions relevant to alcohol-induced psychomotor sensitization. CRF is a neuropeptide in the ated with addiction. Largely observed brain that controls autonomic, hormonal, and behavioral responses to stressors. New data show that CRF with psychostimulant drugs, also has a role in the neuroplasticity associated with addiction. The present study extends the role of CRF psychomotor sensitization has been con- to the psychomotor sensitization associated with repeated administration of alcohol. The hypothalamic- sidered a model for the increased pituitary-adrenal responses produced by CRF appear to be more involved in the acquisition of sensitiza- incentive salience contributing to the tion, whereas extrahypothalamic CRF systems, likely to be in structures such as the amygdala, appear to increased motivation to seek drugs in be important for the expression of sensitization. These results, combined with previous studies on the role of CRF in the development of alcohol dependence, suggest a key role for CRF in the neuroplasticity individuals with a previous history of associated with addiction.
    [Show full text]
  • Urocortin 2 Modulates Glucose Utilization and Insulin Sensitivity in Skeletal Muscle
    Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle Alon Chen*†, Bhawanjit Brar*, Cheol Soo Choi‡, David Rousso*, Joan Vaughan*, Yael Kuperman†, Shee Ne Kim‡, Cindy Donaldson*, Sean M. Smith*, Pauline Jamieson*, Chien Li*, Tim R. Nagy§, Gerald I. Shulman‡, Kuo-Fen Lee*, and Wylie Vale*¶ *Clayton Foundation Laboratories for Peptide Biology, The Salk Institute for Biological Studies, La Jolla, CA 92037; †Department of Neurobiology, The Weizmann Institute of Science, Rehovot 76100, Israel; ‡Department of Internal Medicine and Cellular and Molecular Physiology and Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06536; and §Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL 35294 Contributed by Wylie Vale, August 28, 2006 Skeletal muscle is the principal tissue responsible for insulin- Results and Discussion stimulated glucose disposal and is a major site of peripheral insulin Generation of Ucn 2-Deficient Mice. To explore the physiological resistance. Urocortin 2 (Ucn 2), a member of the corticotropin- role of Ucn 2, we generated mice that are deficient in this releasing factor (CRF) family, and its cognate type 2 CRF receptor peptide. A genomic DNA clone containing Ucn 2 was isolated, (CRFR2) are highly expressed in skeletal muscle. To determine the and a targeting construct in which the full Ucn 2 coding sequence physiological role of Ucn 2, we generated mice that are deficient in was replaced with a neomycin-resistant gene cassette was gen- this peptide. Using glucose-tolerance tests (GTTs), insulin-tolerance erated (Fig. 1a). J1 ES cells were electroporated with the tests (ITTs), and hyperinsulinemic euglycemic glucose clamp stud- targeting construct and were selected as described in ref.
    [Show full text]
  • Multi-Functionality of Proteins Involved in GPCR and G Protein Signaling: Making Sense of Structure–Function Continuum with In
    Cellular and Molecular Life Sciences (2019) 76:4461–4492 https://doi.org/10.1007/s00018-019-03276-1 Cellular andMolecular Life Sciences REVIEW Multi‑functionality of proteins involved in GPCR and G protein signaling: making sense of structure–function continuum with intrinsic disorder‑based proteoforms Alexander V. Fonin1 · April L. Darling2 · Irina M. Kuznetsova1 · Konstantin K. Turoverov1,3 · Vladimir N. Uversky2,4 Received: 5 August 2019 / Revised: 5 August 2019 / Accepted: 12 August 2019 / Published online: 19 August 2019 © Springer Nature Switzerland AG 2019 Abstract GPCR–G protein signaling system recognizes a multitude of extracellular ligands and triggers a variety of intracellular signal- ing cascades in response. In humans, this system includes more than 800 various GPCRs and a large set of heterotrimeric G proteins. Complexity of this system goes far beyond a multitude of pair-wise ligand–GPCR and GPCR–G protein interactions. In fact, one GPCR can recognize more than one extracellular signal and interact with more than one G protein. Furthermore, one ligand can activate more than one GPCR, and multiple GPCRs can couple to the same G protein. This defnes an intricate multifunctionality of this important signaling system. Here, we show that the multifunctionality of GPCR–G protein system represents an illustrative example of the protein structure–function continuum, where structures of the involved proteins represent a complex mosaic of diferently folded regions (foldons, non-foldons, unfoldons, semi-foldons, and inducible foldons). The functionality of resulting highly dynamic conformational ensembles is fne-tuned by various post-translational modifcations and alternative splicing, and such ensembles can undergo dramatic changes at interaction with their specifc partners.
    [Show full text]
  • Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms
    Review Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms Melpomeni Fani 1,*, Petra Kolenc Peitl 2 and Irina Velikyan 3 1 Division of Radiopharmaceutical Chemistry, University Hospital of Basel, 4031 Basel, Switzerland; [email protected] 2 Department of Nuclear Medicine, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia; [email protected] 3 Department of Medicinal Chemistry, Uppsala University, 751 23 Uppsala, Sweden; [email protected] * Correspondence: [email protected]; Tel.: +41-61-556-58-91; Fax: +41-61-265-49-25 Academic Editor: Klaus Kopka Received: 7 February 2017; Accepted: 9 March 2017; Published: 15 March 2017 Abstract: Nuclear medicine plays a pivotal role in the management of patients affected by neuroendocrine neoplasms (NENs). Radiolabeled somatostatin receptor analogs are by far the most advanced radiopharmaceuticals for diagnosis and therapy (radiotheranostics) of NENs. Their clinical success emerged receptor-targeted radiolabeled peptides as an important class of radiopharmaceuticals and it paved the way for the investigation of other radioligand-receptor systems. Besides the somatostatin receptors (sstr), other receptors have also been linked to NENs and quite a number of potential radiolabeled peptides have been derived from them. The Glucagon- Like Peptide-1 Receptor (GLP-1R) is highly expressed in benign insulinomas, the Cholecystokinin 2 (CCK2)/Gastrin receptor is expressed in different NENs, in particular medullary thyroid cancer, and the Glucose-dependent Insulinotropic Polypeptide (GIP) receptor was found to be expressed in gastrointestinal and bronchial NENs, where interestingly, it is present in most of the sstr-negative and GLP-1R-negative NENs. Also in the field of sstr targeting new discoveries brought into light an alternative approach with the use of radiolabeled somatostatin receptor antagonists, instead of the clinically used agonists.
    [Show full text]
  • Download (750Kb)
    The potential role of the novel hypothalamic neuropeptides nesfatin-1, phoenixin, spexin and kisspeptin in the pathogenesis of anxiety and anorexia nervosa. Artur Pałasz a, Małgorzata Janas-Kozik b, Amanda Borrow c, Oscar Arias-Carrión d , John J. Worthington e a Department of Histology, School of Medicine in Katowice, Medical University of Silesia, ul. Medyków 18, 40-752, Katowice, Poland b Department of Psychiatry and Psychotherapy, School of Medicine in Katowice, Medical University of Silesia, ul. Ziolowa 45/47 Katowice, 40-635, Poland c Department of Biomedical Sciences, Colorado State University, Fort Collins, CO, 80523- 161, US d Unidad de Trastornos del Movimiento y Sueño, Hospital General Dr Manuel Gea Gonzalez, Mexico City, Mexico e Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster, LA1 4YQ, UK Abstract Due to the dynamic development of molecular neurobiology and bioinformatic methods several novel brain neuropeptides have been identified and characterized in recent years. Contemporary techniques of selective molecular detection e.g. in situ Real-Time PCR, microdiffusion and some bioinformatics strategies that base on searching for single structural features common to diverse neuropeptides such as hidden Markov model (HMM) have been successfully introduced. A convincing majority of neuropeptides have unique properties as well as a broad spectrum of physiological activity in numerous neuronal pathways including the hypothalamus and limbic system. The newly discovered but uncharacterized regulatory factors nesfatin-1, phoenixin, spexin and kisspeptin have the potential to be unique modulators of stress responses and eating behaviour. Accumulating basic studies revelaed an intriguing role of these neuropeptides in the brain pathways involved in the pathogenesis of anxiety behaviour.
    [Show full text]
  • Urocortin 2 Autocrine/Paracrine and Pharmacologic Effects to Activate AMP-Activated Protein Kinase in the Heart
    Urocortin 2 autocrine/paracrine and pharmacologic effects to activate AMP-activated protein kinase in the heart Ji Lia, Dake Qib, Haiying Chengc, Xiaoyue Hub, Edward J. Millerd, Xiaohong Wub, Kerry S. Russellb, Nicole Mikushb, Jiasheng Zhangb, Lei Xiaoe, Robert S. Sherwinc, and Lawrence H. Youngb,1 aDepartment of Pharmacology and Toxicology, University at Buffalo, The State University of New York, Buffalo, NY 14214; bSection of Cardiovascular Medicine and cSection of Endocrinology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520; dDepartment of Medicine, Boston University, Boston, MA 02118; and eUniversity of Florida Shands Cancer Center, Department of Anatomy and Cell Biology, College of Medicine, Gainesville, FL 32610 Edited* by Gerald I. Shulman, Howard Hughes Medical Institute and Yale University, New Haven, CT, and approved August 9, 2013 (received for review July 11, 2013) Urocortin 2 (Ucn2), a peptide of the corticotropin-releasing factor Ucn2 (5). Signaling pathways have substantial cross-talk, and (CRF) family, binds with high affinity to type 2 CRF receptors pharmacologic inhibitor studies suggest a possible association (CRFR2) on cardiomyocytes and confers protection against ische- between activation of PKCe and the energy-stress kinase AMP- mia/reperfusion. The mechanisms by which the Ucn2-CRFR2 axis activated protein kinase (AMPK) (10). AMPK is activated by mitigates against ischemia/reperfusion injury remain incompletely changes in cellular energetics, but its activity is also modulated
    [Show full text]
  • Urocortin-Dependent Effects on Adrenal Morphology, Growth, and Expression of Steroidogenic Enzymes in Vivo
    159 Urocortin-dependent effects on adrenal morphology, growth, and expression of steroidogenic enzymes in vivo Anna Riester, Ariadni Spyroglou, Adi Neufeld-Cohen1, Alon Chen1 and Felix Beuschlein Endocrine Research Unit, Medizinische Klinik und Poliklinik IV, Hospital of the Ludwig Maximilians University, Ziemssenstrasse 1, D-80336 Munich, Germany 1Department of Neurobiology, Weizmann Institute of Science, Rehovot, Israel (Correspondence should be addressed to F Beuschlein; Email: [email protected]) Abstract Urocortin (UCN) 1, 2, and 3 are members of the corticotropin-releasing factor (CRF) family that display varying affinities to the CRF receptor 1 (CRFR1 (CRHR1)) and 2 (CRFR2 (CRHR2)). UCNs represent important modulators of stress responses and are involved in the control of anxiety and related disorders. In addition to the CNS, UCNs and CRFRs are highly expressed in several tissues including the adrenal gland, indicating the presence of UCN-dependent regulatory mechanisms in these peripheral organ systems. Using knockout (KO) mouse models lacking single or multiple Ucn genes, we examined the potential role of the three different Ucns on morphology and function of the adrenal gland. Adrenal morphology was investigated, organ size, cell size, and number were quantified, and growth kinetics were studied by proliferative cell nuclear antigen staining and Ccnd1 expression analysis. Furthermore, mRNA expression of enzymes involved in steroidogenesis and catecholamine synthesis was quantified by real-time PCR. Following this approach, Ucn2, Ucn1/Ucn2 dKO and Ucn1/Ucn2/Ucn3 tKO animals showed a significant cellular hypotrophy of the adrenal cortex and an increase in Ccnd1 expression, whereas in all other genotypes, no changes were observable in comparison to age-matched controls.
    [Show full text]
  • Potent Mast Cell Degranulation and Vascular Permeability Triggered by Urocortin Through Activation of Corticotropin- Releasing Hormone Receptors1
    0022-3565/99/2883-1349$03.00/0 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 288, No. 3 Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics Printed in U.S.A. JPET 288:1349–1356, 1999 Potent Mast Cell Degranulation and Vascular Permeability Triggered by Urocortin Through Activation of Corticotropin- Releasing Hormone Receptors1 LEENA K. SINGH, WILLIAM BOUCHER, XINZHU PANG, RICHARD LETOURNEAU, DIMITRI SERETAKIS, MARLON GREEN, and THEOHARIS C. THEOHARIDES Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Boston, Massachusetts Accepted for publication October 9, 1998 This paper is available online at http://www.jpet.org ABSTRACT Urocortin (Ucn) is related to corticotropin-releasing hormone antagonist astressin both reduced vascular permeability trig- (CRH), and both are released in the brain under stress where gered by Ucn but not that by Substance P or histamine. In they stimulate CRH 1 and 2 receptors (CRHR). Outside the contrast, the peptide antagonist a-helical CRH-(9–41) reduced brain, they may have proinflammatory actions through activa- the effect of all three. The vasodilatory effect of Ucn was largely tion of mast cells, which are located perivascularly close to inhibited by pretreatment with H1 receptor antagonists, sug- nerve endings and degranulate in response to acute psycho- gesting that histamine is the major mediator involved in vitro. logical stress. Here, we report that a concentration of intrader- Neuropeptide depletion of sensory neurons, treatment with the mal Ucn as low as 10 nM induced dose-dependent rat skin ganglionic blocker hexamethonium, or in situ skin infiltration mast cell degranulation and increased vascular permeability.
    [Show full text]
  • Phenotypic Characterization of Urocortin 3 in the Paraventricular Nucleus of the Hypothalamus
    i Phenotypic characterization of Urocortin 3 in the paraventricular nucleus of the hypothalamus Christine van Hover Annapolis, MD Bachelor of Science, University of Maryland 2009 A Dissertation presented to the Graduate Faculty of the University of Virginia in Candidacy for the Degree of Doctor of Philosophy Neuroscience Graduate Program University of Virginia May 2015 Chien Li, PhD (Dissertation advisor) Ignacio Provencio, PhD (Executive committee member) Patrice Guyenet, PhD Edward Perez-Reyes, PhD Craig Nunemaker, PhD i Abstract Regulation of food intake and energy expenditure is crucial to maintain a stable body weight. Excessive energy intake combined with inadequate energy expenditure leads to obesity, which is co-morbid with many devastating diseases such as cancer, cardiovascular diseases, and infertility. The hypothalamus plays a pivotal role in the regulation of energy balance. It integrates signals from both the external environment and internal milieu to modulate feeding and energy expenditure to maintain energy homeostasis. Neuropeptides are critical molecular mediators underlying many important energy homeostatic functions of the hypothalamus. Thus, a detailed knowledge of the role of hypothalamic peptides and their receptors in controlling feeding, metabolism, and energy expenditure is essential to understand the causes of obesity and related metabolic disorders. Urocortin 3 (Ucn 3) is a member of the corticotropin-releasing factor (CRF) family of peptides. The CRF family plays a critical role in coordinating aspects of the stress response including stimulation of the hypothalamic-pituitary-adrenal axis, behavioral arousal, and energy adaptation through suppression of feeding and promotion of energy mobilization. Centrally-injected Ucn 3 suppresses feeding, elevates blood glucose concentration and body temperature, and stimulates the hypothalamic-pituitary- adrenal axis, indicating that central Ucn 3 may be involved in regulating energy homeostasis and the stress response.
    [Show full text]